Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 23.99% vs 19.49% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 67.24% vs 14.28% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 48.47% vs 20.60% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -32.49% vs 149.90% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Novo Nordisk A/S With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 22.34% vs 5.56% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 23.99% vs 19.49% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 80.57% vs 34.41% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 67.24% vs 14.28% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 68.82% vs 18.75% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 48.47% vs 20.60% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -32.49% vs 149.90% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






